IRIS
DELLA CORTE, Carminia Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.433
NA - Nord America 1.144
AS - Asia 121
AF - Africa 2
SA - Sud America 2
OC - Oceania 1
Totale 2.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.122
IE - Irlanda 630
IT - Italia 351
GB - Regno Unito 101
DE - Germania 97
FR - Francia 90
UA - Ucraina 72
CN - Cina 64
GR - Grecia 34
CA - Canada 22
FI - Finlandia 21
VN - Vietnam 20
SE - Svezia 15
TR - Turchia 12
BE - Belgio 9
IN - India 6
JP - Giappone 6
AT - Austria 3
NL - Olanda 3
PK - Pakistan 3
SG - Singapore 3
CZ - Repubblica Ceca 2
ES - Italia 2
HK - Hong Kong 2
HU - Ungheria 2
IL - Israele 2
AU - Australia 1
BR - Brasile 1
CL - Cile 1
IQ - Iraq 1
IR - Iran 1
MA - Marocco 1
PL - Polonia 1
PS - Palestinian Territory 1
SC - Seychelles 1
Totale 2.703
Salva come PNG Salva come JPEG
Città #
Dublin 622
Chandler 286
Jacksonville 137
Naples 76
Princeton 73
New York 72
Roxbury 72
Bremen 62
Beijing 41
Cambridge 37
Medford 36
Caserta 33
Wilmington 24
Dong Ket 20
Elora 19
Des Moines 17
Napoli 17
Ann Arbor 15
Ashburn 15
Boardman 13
Brussels 9
Lappeenranta 7
Munich 6
Pozzuoli 6
San Mateo 6
Woodbridge 6
Acerra 5
Battipaglia 5
Nanjing 5
Somma Vesuviana 5
London 4
Mountain View 4
Norwalk 4
Rome 4
Shanghai 4
Amsterdam 3
Ercolano 3
Fairfield 3
Helsinki 3
Houston 3
Jinan 3
Milan 3
Scafati 3
Singapore 3
Toronto 3
Vienna 3
Anantapur 2
Andover 2
Athens 2
Avellino 2
Aversa 2
Bat Hefer 2
Caivano 2
Cinquevie 2
Corbara 2
Delhi 2
Elmas 2
Florence 2
Giugliano in Campania 2
Hanover 2
Hong Kong 2
L'aquila 2
Lustra 2
Madrid 2
Menlo Park 2
Nanchang 2
Pagani 2
Paris 2
San Nicola la Strada 2
Strasbourg 2
Zhengzhou 2
Antea 1
Atlanta 1
Bari 1
Barra Mansa 1
Bedizzole 1
Benevento 1
Bezons 1
Borispol 1
Brdo 1
Brno 1
Casalnuovo di Napoli 1
Cava De' Tirreni 1
Cercola 1
Cervo 1
Changsha 1
Düsseldorf 1
Genova 1
Guangzhou 1
Guido 1
Gunzenhausen 1
Heidelberg 1
Hyderabad 1
Indore 1
Lviv 1
Mahé 1
Mantova 1
Marcianise 1
Marco 1
Marigliano 1
Totale 1.879
Salva come PNG Salva come JPEG
Nome #
EPHA2 is a predictive biomarker of resistance and a potential therapeutic target for improving anti-epidermal growth factor receptor therapy in colorectal cancer 91
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells 71
A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non-Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial. 70
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 62
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 57
Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures 56
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 56
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: Case report and translational study 53
Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer 51
A trimodality, four-step treatment including chemotherapy, pleurectomy/decortication and radiotherapy in early-stage malignant pleural mesothelioma: A single-institution retrospective case series study 51
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 50
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 49
Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis 48
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 47
Present and future of metastatic colorectal cancer treatment: A review of new candidate targets 46
Mechanisms of resistance to EGFR-targeted drugs: lung cancer 45
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials 45
Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer. 44
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines 44
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR. 44
Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype 44
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 43
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 43
Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence. 42
Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial 42
Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer 41
Which treatment after first line therapy in NSCLC patients without genetic alterations in the era of immunotherapy? 41
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 40
Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models 39
Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy 39
Antitumor efficacy of triple monoclonal antibody inhibition of epidermal growth factor receptor (EGFR) with MM151 in EGFRdependent and in cetuximab-resistant human colorectal cancer cells 38
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines 38
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer 37
ROLE OF THE HEDGEHOG PATHWAY IN MEDIATING RESISTANCE TO ANTI-EGFR TYROSINE KINASE INHIBITORS IN NON SMALL CELL LUNG CANCER 36
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 36
Dramatic Therapeutic Response to Dabrafenib Plus Trametinib in BRAF V600E Mutated Papillary Craniopharyngiomas: A Case Report and Literature Review 34
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gastrointestinal Tract: A Case Series 34
Primary pleural squamous cell carcinoma: A diagnostic challenge 33
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer 33
Multi-Omic Approaches in Colorectal Cancer beyond Genomic Data 33
Immunotherapy for head and neck cancer: Present and future 32
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 32
Role and targeting of anaplastic lymphoma kinase in cancer 31
How immunotherapy has changed the continuum of care in hepatocellular carcinoma 31
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy 30
Beyond chemotherapy: Emerging biomarkers and therapies as small cell lung cancer enters the immune checkpoint era 29
Inherited predisposition to malignant mesothelioma: germline BAP1 mutations and beyond 29
Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC 28
AXL inhibition induces DNA damage and replication stress in non-small cell lung cancer cells and promotes sensitivity to ATR inhibitors 27
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening? 27
Prediction of preoperative intrathoracic adhesions for ipsilateral reoperations: sliding lung sign 26
Early use of steroids affects immune cells and impairs immunotherapy efficacy 26
Feasibility of next-generation sequencing in clinical practice: Results of a pilot study in the Department of Precision Medicine at the University of Campania ' Luigi Vanvitelli' 26
Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy 26
Translational insights and new therapeutic perspectives in head and neck tumors 26
Implication of the Hedgehog pathway in hepatocellular carcinoma. 25
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells 25
Beyond N staging in colorectal cancer: Current approaches and future perspectives 24
Kisspeptin and cancer: Molecular interaction, biological functions, and future perspectives 24
Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer 24
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers 22
The role of coronary artery calcification score in lung cancer patients 22
Evading the STING: LKB1 loss leads to STING silencing and immune escape in KRAS-mutant lung cancers 22
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis 22
Ventilation challenge in rigid bronchoscopy: Laser tube as an alternative management in patients with lung cancer and central airway obstruction 22
Diagnosis of malignant pleural disease: Ultrasound as "a detective probe" 20
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors 20
Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients 20
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy 18
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists 18
Hypothalamic–pituitary autoimmunity in patients treated with anti-pd-1 and anti-pd-l1 antibodies 18
Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR 17
Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer 16
ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer 16
The use of ultrasound in the evaluation of postoperative pneumothorax and lung re-expansion in patients after lung resection 16
Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human BRAFV600E mutant colorectal cancer 16
Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC 15
A Critical Issue in Lung Cancer Cytology and Small Biopsies: DNA and RNA Extraction from Archival Stained Slides for Biomarker Detection through Real Time PCR and NGS-The Experience in Pathological Anatomy Unit 15
AXL and MET Tyrosine Kinase Receptors Co-Expression as a Potential Therapeutic Target in Malignant Pleural Mesothelioma 14
CARdioimaging in Lung Cancer PatiEnts Undergoing Radical RadioTherapy: CARE-RT Trial 14
Role of HGF-MET signaling in primary and acquired resistance to targeted therapies in cancer 14
Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer 13
Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 12
Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA 12
STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype 11
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities 11
Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology 11
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 11
Small bowel metastasis from pancreatic cancer in a long-term survival patient with synchronous advanced malignant pleural mesothelioma: A case report and literature review 7
Post-Irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review 6
The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems 5
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 5
Asymptomatic azygos vein overflow in a young patient with primary mediastinal seminoma 5
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 3
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy 1
Totale 2.884
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.643
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201923 0 0 0 0 0 0 0 0 0 2 18 3
2019/2020264 47 33 14 12 28 6 47 20 26 18 11 2
2020/2021213 8 5 16 4 18 6 42 19 15 16 38 26
2021/2022510 9 7 10 9 112 10 45 18 26 37 68 159
2022/20231.209 118 30 25 114 129 93 12 58 566 13 30 21
2023/2024467 61 25 24 32 173 82 20 24 11 15 0 0
Totale 2.884